2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European …

H Baumgartner, J De Backer… - European heart …, 2021 - academic.oup.com
Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

Evidence from clinical trials on high-risk medical devices in children: a scoping review

K Guerlich, B Patro-Golab, P Dworakowski… - Pediatric …, 2024 - nature.com
Background Meeting increased regulatory requirements for clinical evaluation of medical
devices marketed in Europe in accordance with the Medical Device Regulation (EU …

Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography …

WA Zoghbi, FM Asch, C Bruce, LD Gillam… - Journal of the American …, 2019 - Elsevier
Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

[HTML][HTML] Pulmonary valve replacement for tetralogy of Fallot

D Balzer - Methodist DeBakey cardiovascular journal, 2019 - ncbi.nlm.nih.gov
Right ventricular outflow tract (RVOT) dysfunction is common following surgical repair of
tetralogy of Fallot and other forms of complex congenital heart disease. This results in …

Transcatheter pulmonary valve replacement with the sapien prosthesis

S Shahanavaz, EM Zahn, DS Levi… - Journal of the American …, 2020 - jacc.org
Background There are limited published data focused on outcomes of transcatheter
pulmonary valve replacement (TPVR) with either a Sapien XT or Sapien 3 (S3) valve …

Alterra adaptive prestent and SAPIEN 3 THV for congenital pulmonic valve dysfunction: an early feasibility study

S Shahanavaz, D Balzer, V Babaliaros, D Kim… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to demonstrate the safety and functionality of the Alterra
Adaptive Prestent and SAPIEN 3 transcatheter heart valve (THV) in patients with …

Three-year outcomes from the harmony native outflow tract early feasibility study

LN Benson, MJ Gillespie, L Bergersen… - Circulation …, 2020 - Am Heart Assoc
Background: The Harmony transcatheter pulmonary valve (TPV) was designed for treatment
of postoperative pulmonary valve regurgitation in patients with repaired right ventricular …

Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: a multicenter pediatric heart network scholar …

MH Martin, J Meadows, DB McElhinney… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study sought to determine the safety and feasibility of transcatheter
pulmonary valve replacement (TPVR) using the Melody valve in native (nonconduit) right …

Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry

S Hascoët, JR Bentham, L Giugno… - European Heart …, 2024 - academic.oup.com
Abstract Background and Aims Transcatheter pulmonary valve implantation (TPVI) is
indicated to treat right-ventricular outflow tract (RVOT) dysfunction related to congenital heart …

[HTML][HTML] 5-year outcomes from the harmony native outflow tract early feasibility study

MJ Gillespie, L Bergersen, LN Benson, S Weng… - Cardiovascular …, 2021 - jacc.org
The initial clinical evaluation of the Harmony transcatheter pulmonary valve (TPV) was
conducted under the auspices of the Harmony early feasibility study (EFS)(Native Outflow …